Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Antolin AA"'
Autor:
Sanfelice D; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Antolin AA; proCURE Department, Oncobell Program, Catalan Institute of Oncology (ICO) and Bellvitge Biomedical Research Institute (IDIBELL), Hospital Duran y Reynals Avinguda de la Gran Via, 199, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Chemical Probes Portal, www.chemicalprobes.org., Crisp A; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Chen Y; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Bellenie B; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Brennan PE; Centre for Medicines Discovery, Nuffield Department of Medicine, NDM Research Building, University of Oxford, Oxford OX3 7FZ, UK.; Chemical Probes Portal, www.chemicalprobes.org., Edwards A; Structural Genomics Consortium, MaRS Centre, South Tower, 101 College St., Suite 700, Toronto, ON M5G 1L7, Canada.; Chemical Probes Portal, www.chemicalprobes.org., Müller S; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK.; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Johann Wolfgang Goethe-University, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.; Chemical Probes Portal, www.chemicalprobes.org., Al-Lazikani B; Department of Genomic Medicine and the Institute for Data Science in Oncology, UT MD Anderson, University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, TX 77054, USA.; Chemical Probes Portal, www.chemicalprobes.org., Workman P; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2024 Nov 18. Date of Electronic Publication: 2024 Nov 18.
Autor:
Feng B; Department of Pharmacy, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225000, P. R. China., Yu H; Information School, University of Sheffield, 211 Portobello, Sheffield, S1 4DP, U.K., Dong X; Department of Pharmacy, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225000, P. R. China., Díaz-Holguín A; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, BMC, Box 596, SE-751 24, Uppsala, Sweden., Antolin AA; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SW7 3RP, U.K.; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia 08907, Spain., Hu H; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, BMC, Box 596, SE-751 24, Uppsala, Sweden.; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SW7 3RP, U.K.
Publikováno v:
Journal of chemical information and modeling [J Chem Inf Model] 2024 Oct 14; Vol. 64 (19), pp. 7725-7742. Date of Electronic Publication: 2024 Sep 18.
Autor:
Antolin AA, Aye Y, Bar-Peled L, De Vita E, Dudkina N, Jewett MC, Kiely-Collins H, Mazitschek R, Zhang ZJ
Publikováno v:
Cell chemical biology [Cell Chem Biol] 2024 Sep 19; Vol. 31 (9), pp. 1562-1565.
Autor:
Manen-Freixa L; Oncobell Division, Bellvitge Biomedical Research Institute (IDIBELL) and ProCURE Department, Catalan Institute of Oncology (ICO), Barcelona, Spain., Antolin AA; Oncobell Division, Bellvitge Biomedical Research Institute (IDIBELL) and ProCURE Department, Catalan Institute of Oncology (ICO), Barcelona, Spain.; Center for Cancer Drug Discovery, The Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
Publikováno v:
Expert opinion on drug discovery [Expert Opin Drug Discov] 2024 Sep; Vol. 19 (9), pp. 1043-1069. Date of Electronic Publication: 2024 Jul 14.
Autor:
Hu LZ, Douglass E, Turunen M, Pampou S, Grunn A, Realubit R, Antolin AA, Wang ALE, Li H, Subramaniam P, Mundi PS, Karan C, Alvarez M, Califano A
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 27. Date of Electronic Publication: 2024 Jun 27.
Autor:
Hu H; Center for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK., Serra C; Medicinal Chemistry and Synthesis (MCS) Laboratory, Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain; Synthesis of High Added Value Molecules (SIMChem), Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain., Zhang W; ProCURE, Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Catalonia, Spain., Scrivo A; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain., Fernández-Carasa I; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain., Consiglio A; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Aytes A; ProCURE, Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Catalonia, Spain., Pujana MA; ProCURE, Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Catalonia, Spain., Llebaria A; Medicinal Chemistry and Synthesis (MCS) Laboratory, Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain; Synthesis of High Added Value Molecules (SIMChem), Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain. Electronic address: amadeu.llebaria@iqac.csic.es., Antolin AA; Center for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK; ProCURE, Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Catalonia, Spain. Electronic address: albert.antolin@icr.ac.uk.
Publikováno v:
Cell chemical biology [Cell Chem Biol] 2024 May 16; Vol. 31 (5), pp. 973-988.e4. Date of Electronic Publication: 2024 Feb 08.
Autor:
Walpole IR; Department of Medical Oncology, The Alfred Hospital, Melbourne, Australia., Zaman FY; Department of Medical Oncology, The Alfred Hospital, Melbourne, Australia., Zhao P; School of Translational Medicine, Monash University, Melbourne, Australia., Marshall VM; School of Translational Medicine, Monash University, Melbourne, Australia., Lin FP; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.; Garvan Institute of Medical Research, St Vincent's Clinical School, Faculty of Medicine, UNSW, Darlinghurst, Australia., Thomas DM; Garvan Institute of Medical Research, St Vincent's Clinical School, Faculty of Medicine, UNSW, Darlinghurst, Australia., Shackleton M; Department of Medical Oncology, The Alfred Hospital, Melbourne, Australia.; School of Translational Medicine, Monash University, Melbourne, Australia., Antolin AA; ProCURE, Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain.; The Division of Cancer Therapeutics, Center for Cancer Drug Discovery, The Institute of Cancer Research, London, UK., Ameratunga M; Department of Medical Oncology, The Alfred Hospital, Melbourne, Australia.; School of Translational Medicine, Monash University, Melbourne, Australia.
Publikováno v:
Clinical and translational medicine [Clin Transl Med] 2024 Apr; Vol. 14 (4), pp. e1657.
Autor:
Bellot M; Department of Analytical and Applied Chemistry, School of Engineering, Institut Químic de Sarrià-Universitat Ramon Llull, 08017 Barcelona, Spain. Electronic address: marina.bellot@iqs.url.edu., Manen L; proCURE, Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Prats E; Research and Development Center (CID-CSIC), 08034 Barcelona, Spain., Bedrossiantz J; Institute for Environmental Assessment and Water Research (IDAEA-CSIC), 08034 Barcelona, Spain., Barata C; Institute for Environmental Assessment and Water Research (IDAEA-CSIC), 08034 Barcelona, Spain., Gómez-Canela C; Department of Analytical and Applied Chemistry, School of Engineering, Institut Químic de Sarrià-Universitat Ramon Llull, 08017 Barcelona, Spain., Antolin AA; proCURE, Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Raldúa D; Institute for Environmental Assessment and Water Research (IDAEA-CSIC), 08034 Barcelona, Spain. Electronic address: drpqam@cid.csic.es.
Publikováno v:
The Science of the total environment [Sci Total Environ] 2024 Feb 20; Vol. 912, pp. 169301. Date of Electronic Publication: 2023 Dec 14.
A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis.
Autor:
Hu H; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, BMC, Box 596, SE-751 24 Uppsala, Sweden., Tjaden A; Institute of Pharmaceutical Chemistry, Johann Wolfgang Goethe University, 60438 Frankfurt am Main, Germany; Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Johann Wolfgang Goethe University, 60438 Frankfurt am Main, Germany., Knapp S; Institute of Pharmaceutical Chemistry, Johann Wolfgang Goethe University, 60438 Frankfurt am Main, Germany; Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Johann Wolfgang Goethe University, 60438 Frankfurt am Main, Germany., Antolin AA; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia Barcelona, Spain. Electronic address: aantolin@idibell.cat., Müller S; Institute of Pharmaceutical Chemistry, Johann Wolfgang Goethe University, 60438 Frankfurt am Main, Germany; Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Johann Wolfgang Goethe University, 60438 Frankfurt am Main, Germany. Electronic address: susanne.mueller-knapp@bmls.de.
Publikováno v:
Cell chemical biology [Cell Chem Biol] 2023 Dec 21; Vol. 30 (12), pp. 1634-1651.e6. Date of Electronic Publication: 2023 Oct 04.
Autor:
Ackloo S; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca., Antolin AA; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL) L'Hospitalet del Llobregat Barcelona Catalonia Spain aantolin@idibell.cat., Bartolome JM; A Division of Janssen-Cilag S.A., Janssen Research and Development Toledo Spain jbartolo@its.jnj.com JLlaveri@ITS.JNJ.com., Beck H; Research and Development, Bayer AG, Pharmaceuticals 42103 Wuppertal Germany hartmut.beck@bayer.com jan.dreher@bayer.com alexander.hillisch@bayer.com., Bullock A; Center for Medicines Discovery, Old Road Campus, University of Oxford Roosevelt Drive, Headington Oxford OX3 7DQ UK alex.bullock@cmd.ox.ac.uk jon.elkins@cmd.ox.ac.uk., Betz UAK; Merck KGaA Darmstadt Germany ulrich.betz@merckgroup.com Sven.Lindemann@merckgroup.com., Böttcher J; Boehringer Ingelheim RCV GmbH & Co KG Vienna Austria jark.boettcher@boehringer-ingelheim.com., Brown PJ; Structural Genomics Consortium, University of North Carolina at Chapel Hill USA peter.brown@unc.edu., Chaturvedi M; Boehringer Ingelheim International Binger Str. 173 D-55216 Ingelheim Germany menorca.chaturvedi@boehringer-ingelheim.com markus.koester@boehringer-ingelheim.com oliver.kraemer@boehringer-ingelheim.com., Crisp A; Division of Cancer Therapeutics, The Institute of Cancer Research London SM2 5NG UK Alisa.crisp@icr.ac.uk., Daniels D; Foghorn Therapeutics 500 Technology Square, Suite 700 Cambridge MA 02139 USA DDaniels@foghorntx.com., Dreher J; Research and Development, Bayer AG, Pharmaceuticals 42103 Wuppertal Germany hartmut.beck@bayer.com jan.dreher@bayer.com alexander.hillisch@bayer.com., Edfeldt K; Structural Genomics Consortium, Department of Medicine, Karolinska University Hospital and Karolinska Institutet Stockholm Sweden kristina.edfeldt@ki.se michael.sundstrom@ki.se., Edwards AM; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca., Egner U; Nuvisan Innovation Campus Berlin GmbH Müllerstraße 178 13353 Berlin Germany egner.target2035@web.de anke.mueller-fahrnow@nuvisan.com., Elkins J; Center for Medicines Discovery, Old Road Campus, University of Oxford Roosevelt Drive, Headington Oxford OX3 7DQ UK alex.bullock@cmd.ox.ac.uk jon.elkins@cmd.ox.ac.uk., Fischer C; Discovery Chemistry, Merck & Co., Inc. Boston Massachusetts 02115 USA christian_fischer@merck.com., Glendorf T; Research & Early Development, Novo Nordisk A/S Måløv Denmark tgle@novonordisk.com lrli@novonordisk.com., Goldberg S; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com., Hartung IV; Medicinal Chemistry, Global R&D, Merck Healthcare KGaA Frankfurter Straße 250 64293 Darmstadt Germany ingo.hartung@merckgroup.com., Hillisch A; Research and Development, Bayer AG, Pharmaceuticals 42103 Wuppertal Germany hartmut.beck@bayer.com jan.dreher@bayer.com alexander.hillisch@bayer.com., Homan E; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet Stockholm Sweden evert.homan@ki.se maurice.grube@scilifelab.se., Knapp S; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de tredup@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt Frankfurt 60438 Germany susanne.mueller-knapp@bmls.de., Köster M; Boehringer Ingelheim International Binger Str. 173 D-55216 Ingelheim Germany menorca.chaturvedi@boehringer-ingelheim.com markus.koester@boehringer-ingelheim.com oliver.kraemer@boehringer-ingelheim.com., Krämer O; Boehringer Ingelheim International Binger Str. 173 D-55216 Ingelheim Germany menorca.chaturvedi@boehringer-ingelheim.com markus.koester@boehringer-ingelheim.com oliver.kraemer@boehringer-ingelheim.com., Llaveria J; A Division of Janssen-Cilag S.A., Janssen Research and Development Toledo Spain jbartolo@its.jnj.com JLlaveri@ITS.JNJ.com., Lessel U; Boehringer Ingelheim Pharma GmbH & Co. KG Birkendorfer Str. 65 D-88397 Biberach an der Riss Germany uta.lessel@boehringer-ingelheim.com., Lindemann S; Merck KGaA Darmstadt Germany ulrich.betz@merckgroup.com Sven.Lindemann@merckgroup.com., Linderoth L; Research & Early Development, Novo Nordisk A/S Måløv Denmark tgle@novonordisk.com lrli@novonordisk.com., Matsui H; Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited Fujisawa Kanagawa Japan hisanori.matsui@takeda.com., Michel M; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet Stockholm Sweden evert.homan@ki.se maurice.grube@scilifelab.se., Montel F; Boehringer Ingelheim Pharma GmbH & Co. KG Birkendorfer Str. 65 D-88397 Biberach an der Riss Germany florian.montel@boehringer-ingelheim.com., Mueller-Fahrnow A; Nuvisan Innovation Campus Berlin GmbH Müllerstraße 178 13353 Berlin Germany egner.target2035@web.de anke.mueller-fahrnow@nuvisan.com., Müller S; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de tredup@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt Frankfurt 60438 Germany susanne.mueller-knapp@bmls.de., Owen DR; Discovery Network Group, Pfizer Medicine Design Cambridge MA 02139 USA Dafydd.Owen@pfizer.com., Saikatendu KS; Global Research Externalization, Takeda California, Inc. 9625 Towne Center Drive San Diego CA 92121 USA kumar.saikatendu@takeda.com., Santhakumar V; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca., Sanderson W; Janssen Research & Development, Janssen Pharmaceutica N. V Beerse Belgium WSANDERS@its.jnj.com., Scholten C; Research and Development, Bayer AG, Pharmaceuticals 13353 Berlin Germany cora.scholten@bayer.com., Schapira M; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca.; Department of Pharmacology & Toxicology, University of Toronto Toronto Ontario M5S 1A8 Canada., Sharma S; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com., Shireman B; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com., Sundström M; Structural Genomics Consortium, Department of Medicine, Karolinska University Hospital and Karolinska Institutet Stockholm Sweden kristina.edfeldt@ki.se michael.sundstrom@ki.se., Todd MH; School of Pharmacy, University College London London WC1N 1AX UK mattoddchem@gmail.com., Tredup C; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de tredup@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt Frankfurt 60438 Germany susanne.mueller-knapp@bmls.de., Venable J; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com., Willson TM; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA tim.willson@unc.edu., Arrowsmith CH; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca.; Princess Margaret Cancer Centre Toronto Ontario M5G 1L7 Canada.
Publikováno v:
RSC medicinal chemistry [RSC Med Chem] 2023 Mar 16; Vol. 14 (6), pp. 1002-1011. Date of Electronic Publication: 2023 Mar 16 (Print Publication: 2023).